https://www.pharmaradar360.com/article/national-digital-health-index-shows-communities-most-at-risk-of-being-left-behin-9017b74e698d51e6Pharma Surgeen2026-06-18T16:49:21.000ZNational Digital Health Index shows communities most at risk of being left behind in the digital health erahttps://www.pharmaradar360.com/article/local-healthcare-executive-to-lead-2026-heart-walk-and-region-wide-push-for-cpr-0446b14e981d930aPharma Surgeen2026-06-18T16:37:00.000ZLocal healthcare executive to lead 2026 Heart Walk and region-wide push for CPR readinesshttps://www.pharmaradar360.com/article/we-all-just-want-to-feel-seen-heard-and-belong-una-europa-staff-week-etsi-tapoja-bee878b994a2794fPharma Surgeen2026-06-18T16:30:55.000Z“We all just want to feel seen, heard, and belong” – Una Europa Staff Week etsi tapoja katsoa yliopistoa uusin silminhttps://www.pharmaradar360.com/article/american-heart-association-names-2026-heart-of-cleveland-guiding-values-awards-w-57c7588000dbc7baPharma Surgeen2026-06-18T16:27:00.000ZAmerican Heart Association names 2026 Heart of Cleveland Guiding Values Awards Winnershttps://www.pharmaradar360.com/article/idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings-4df6f50e861b733aPharma Surgeen2026-06-18T16:18:06.000ZIDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filingshttps://www.pharmaradar360.com/article/nwsl-s-racing-louisville-fc-participate-in-hands-only-cpr-and-aed-training-43a8184909506fd7Pharma Surgeen2026-06-18T16:11:00.000ZNWSL’S Racing Louisville FC participate in Hands-Only CPR and AED traininghttps://www.pharmaradar360.com/article/upcite-launches-its-reporting-platform-f07b448c4079925dPharma Surgeen2026-06-18T16:06:24.000ZUPCité launches its reporting platformhttps://www.pharmaradar360.com/article/denzel-ward-del-equipo-cleveland-browns-y-la-olimpica-katie-moon-lideran-la-camp-14fe9be959396acePharma Surgeen2026-06-18T16:04:00.000ZDenzel Ward del equipo Cleveland Browns y la olímpica Katie Moon lideran la campaña de Cleveland instando a los residentes a actuar como socorristashttps://www.pharmaradar360.com/article/la-american-heart-association-delta-dental-y-goodwill-inauguran-un-nuevo-centro-d4d23938268c6585Pharma Surgeen2026-06-18T16:01:00.000ZLa American Heart Association, Delta Dental y Goodwill inauguran un nuevo centro de control de la presión arterial para ampliar el acceso a la salud en la comunidadhttps://www.pharmaradar360.com/article/la-propuesta-de-un-salon-para-fumadores-en-el-dtw-pone-en-riesgo-las-medidas-de-30d1bcf1b92f626bPharma Surgeen2026-06-18T15:49:00.000ZLa propuesta de un salón para fumadores en el DTW pone en riesgo las medidas de protección contra el humohttps://www.pharmaradar360.com/article/northwestern-medicine-collaborates-with-vizlitics-to-advance-cancer-clinical-tri-ba7d60aeab07b483Pharma Surgeen2026-06-18T15:46:49.000ZNorthwestern Medicine Collaborates with Vizlitics to Advance Cancer Clinical Trial Recruitment and Real-World Datahttps://www.pharmaradar360.com/article/el-chicago-stars-de-la-nwsl-participa-en-el-entrenamiento-de-rcp-solo-con-las-ma-bfc5e6f0c75be23fPharma Surgeen2026-06-18T15:46:00.000ZEl Chicago Stars de la NWSL participa en el entrenamiento de RCP solo con las manos y el uso del DEAhttps://www.pharmaradar360.com/article/at-fda-caretaker-mode-is-better-than-power-trip-mode-2741cd1139c3d247Pharma Surgeen2026-06-18T15:44:10.000ZAt FDA, ‘caretaker mode’ is better than power trip modehttps://www.pharmaradar360.com/article/message-from-the-chair-of-the-department-of-internal-medicine-961ed43f87c3df56Pharma Surgeen2026-06-18T15:35:38.000ZMessage from the Chair of the Department of Internal Medicinehttps://www.pharmaradar360.com/article/the-role-of-immigrants-in-the-u-s-health-care-workforce-1501c2c122625330Pharma Surgeen2026-06-18T15:28:50.000ZThe Role of Immigrants in the U.S. Health Care Workforcehttps://www.pharmaradar360.com/article/h-dele-davies-md-appointed-ninth-chancellor-of-unmc-8de91ad96baec6eaPharma Surgeen2026-06-18T15:26:32.000ZH. Dele Davies, MD, appointed ninth chancellor of UNMChttps://www.pharmaradar360.com/article/first-year-phd-students-applications-for-an-international-dual-phd-programme-are-e6db84bec540a533Pharma Surgeen2026-06-18T15:00:42.000ZFirst-year PhD students: applications for an International dual PhD programme are now open.https://www.pharmaradar360.com/article/new-study-projects-thousands-of-preventable-deaths-if-federal-support-for-syring-e9b185ff079f57b0Pharma Surgeen2026-06-18T15:00:00.000ZNew Study Projects Thousands of Preventable Deaths if Federal Support for Syringe Service Programs Is Reducedhttps://www.pharmaradar360.com/article/apple-announces-changes-to-ios-in-brazil-f8220c3c7ad8f694Pharma Surgeen2026-06-18T14:59:41.000ZApple announces changes to iOS in Brazilhttps://www.pharmaradar360.com/article/exploring-the-future-of-inhalation-drug-delivery-2026-cb4353c9a3d4ed7dPharma Surgeen2026-06-18T14:58:59.000ZExploring the Future of Inhalation Drug Delivery 2026https://www.pharmaradar360.com/article/ems-faz-parceria-com-a-norte-americana-biotech-para-desenvolver-tratamentos-de-a-c245865ad61ab7d1Pharma Surgeen2026-06-18T14:54:56.000ZEMS faz parceria com a norte-americana Biotech para desenvolver tratamentos de alta complexidadehttps://www.pharmaradar360.com/article/h-dele-davies-md-appointed-ninth-chancellor-of-unmc-d5bbf62d00092b3aPharma Surgeen2026-06-18T14:53:51.000ZH. Dele Davies, MD, appointed ninth chancellor of UNMChttps://www.pharmaradar360.com/article/qual-e-a-sua-verdade-dermacyd-propoe-olhar-para-a-intimidade-70636438b1162d3bPharma Surgeen2026-06-18T14:53:47.000ZQual é a sua verdade? Dermacyd propõe olhar para a intimidadehttps://www.pharmaradar360.com/article/os-impactos-da-aquisicao-da-medley-pela-ems-b9aba752ad81c452Pharma Surgeen2026-06-18T14:53:15.000ZOs impactos da aquisição da Medley pela EMShttps://www.pharmaradar360.com/article/ems-compra-medley-da-sanofi-e-reforca-aposta-no-mercado-de-genericos-a83009e2b64a0c68Pharma Surgeen2026-06-18T14:52:50.000ZEMS compra Medley da Sanofi e reforça aposta no mercado de genéricoshttps://www.pharmaradar360.com/article/medley-e-da-ems-mas-marcas-continuam-separadas-nas-gondolas-diz-vp-81c3b28404734297Pharma Surgeen2026-06-18T14:52:22.000ZMedley é da EMS, mas marcas continuam separadas nas gôndolas, diz VPhttps://www.pharmaradar360.com/article/ems-quer-ampliar-debate-sobre-obesidade-com-peso-invisivel-a998851e82c30694Pharma Surgeen2026-06-18T14:51:00.000ZEMS quer ampliar debate sobre obesidade com Peso Invisívelhttps://www.pharmaradar360.com/article/wch-pride-panel-supporting-and-affirming-queer-and-trans-people-in-healthcare-d325113a23bdaec2Pharma Surgeen2026-06-18T14:46:44.000ZWCH Pride Panel: Supporting and Affirming Queer and Trans People in Healthcarehttps://www.pharmaradar360.com/article/lauded-for-leadership-4637c708c18d05fbPharma Surgeen2026-06-18T14:45:22.000ZLauded for leadershiphttps://www.pharmaradar360.com/article/ms-spotlight-treating-women-safely-in-and-around-pregnancy-354d3b133e65f7e9Pharma Surgeen2026-06-18T14:41:34.000ZMS Spotlight: Treating Women Safely In and Around Pregnancyhttps://www.pharmaradar360.com/article/sobre-a-ems-3ea5bdafc993bce1Pharma Surgeen2026-06-18T14:40:08.000ZSobre a EMShttps://www.pharmaradar360.com/article/accelerating-qsp-virtual-population-generation-through-active-learning-and-bayes-2985b097cf38f6efPharma Surgeen2026-06-18T14:23:30.000ZAccelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimizationhttps://www.pharmaradar360.com/article/fda-approves-additional-indication-for-capvaxive-in-children-aged-2-17-at-increa-c034236c93bfeb35Pharma Surgeen2026-06-18T14:18:57.000ZFDA Approves Additional Indication for Capvaxive in Children Aged 2-17 at Increased Risk for Pneumococcal Diseasehttps://www.pharmaradar360.com/article/prix-gustave-roussy-2027-l-appel-a-candidatures-est-ouvert-ce4289b6ee2e3599Pharma Surgeen2026-06-18T14:06:19.000ZPrix Gustave Roussy 2027 : l’appel à candidatures est ouverthttps://www.pharmaradar360.com/article/chemaxon-presents-too-many-tools-not-enough-chemistry-1f237c44aef48aabPharma Surgeen2026-06-18T14:00:34.000ZChemaxon presents: Too Many Tools, Not Enough Chemistryhttps://www.pharmaradar360.com/article/mabion-reactivates-mabioncd20-through-rare-disease-collaboration-with-oddifact-ad71a7d1ef1961ebPharma Surgeen2026-06-18T13:57:15.000ZMabion reactivates MabionCD20 through rare disease collaboration with Oddifacthttps://www.pharmaradar360.com/article/placental-abruption-could-increase-risk-of-cardiovascular-disease-in-women-656a6b718e9b78f6Pharma Surgeen2026-06-18T13:51:41.000ZPlacental abruption could increase risk of cardiovascular disease in womenhttps://www.pharmaradar360.com/article/fda-approves-utebzi-for-adults-with-complicated-urinary-tract-infections-3bd1380a653184b7Pharma Surgeen2026-06-18T13:51:21.000ZFDA Approves Utebzi for Adults with Complicated Urinary Tract Infectionshttps://www.pharmaradar360.com/article/hlth-europe-2026-incorporating-rwe-into-practice-the-perks-and-pitfalls-9b02438398a7af0aPharma Surgeen2026-06-18T13:47:37.000ZHLTH Europe 2026: incorporating RWE into practice – the perks and pitfallshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-57cac49365d67c00Pharma Surgeen2026-06-18T13:41:26.000ZTracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements: Related Resourceshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-c89dc3ea861eea1bPharma Surgeen2026-06-18T13:41:21.000ZTracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements: 1115-waivershttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-c3e1548543288cbdPharma Surgeen2026-06-18T13:41:16.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Implementation Questionshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-a26b55418fff3fa2Pharma Surgeen2026-06-18T13:41:12.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Data and Policieshttps://www.pharmaradar360.com/article/biogen-enters-1-billion-agreement-to-acquire-raythera-inc-ea1ba758d78c6b48Pharma Surgeen2026-06-18T13:30:09.000ZBiogen Enters $1 Billion Agreement to Acquire RayThera Inc.https://www.pharmaradar360.com/article/travaux-sur-le-reseau-de-tram-du-29-juin-au-28-aout-2026-d2be5b887c7bf56dPharma Surgeen2026-06-18T13:29:58.000ZTravaux sur le réseau de tram du 29 juin au 28 août 2026https://www.pharmaradar360.com/article/new-kpmg-powered-accelerator-lands-customers-faster-425841ff6ac975b4Pharma Surgeen2026-06-18T13:25:27.000ZNew KPMG-powered accelerator lands customers fasterhttps://www.pharmaradar360.com/article/pobreza-por-que-la-baja-que-muestran-los-datos-oficiales-podria-estar-sobreestim-a70a1c7b3c9734e1Pharma Surgeen2026-06-18T13:23:55.000ZPobreza: por qué la baja que muestran los datos oficiales podría estar sobreestimadahttps://www.pharmaradar360.com/article/el-impacto-de-la-inseguridad-alimentaria-en-las-infancias-platenses-85f1bc1560537681Pharma Surgeen2026-06-18T13:23:10.000ZEl impacto de la inseguridad alimentaria en las infancias platenseshttps://www.pharmaradar360.com/article/china-sets-framework-for-advanced-therapeutic-development-b3a70f68245111c6Pharma Surgeen2026-06-18T13:20:15.000ZChina Sets Framework for Advanced Therapeutic Developmenthttps://www.pharmaradar360.com/article/labgenius-therapeutics-and-lg-chem-enter-a-research-collaboration-option-and-lic-5ada465d9f9405a7Pharma Surgeen2026-06-18T13:17:19.000ZLabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibodyhttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-9a28fa39f2430cf8Pharma Surgeen2026-06-18T13:15:53.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirementshttps://www.pharmaradar360.com/article/from-tokenism-to-trust-what-inclusive-research-looks-like-d3a41e079ecce017Pharma Surgeen2026-06-18T13:15:23.000ZFrom tokenism to trust – what inclusive research looks likehttps://www.pharmaradar360.com/article/la-unlp-consolida-su-lugar-a-nivel-nacional-y-se-mantiene-entre-las-mejores-del-3484f0008b02fbb6Pharma Surgeen2026-06-18T13:12:39.000ZLa UNLP consolida su lugar a nivel nacional y se mantiene entre las mejores del mundo en el ranking QShttps://www.pharmaradar360.com/article/palabras-del-presidente-fernando-tauber-en-el-inicio-de-su-gestion-2026-2030-c68fc4e36b70c407Pharma Surgeen2026-06-18T13:10:40.000ZPalabras del Presidente Fernando Tauber en el inicio de su gestión 2026-2030https://www.pharmaradar360.com/article/memoria-y-compromiso-a-11-anos-de-ni-una-menos-78797e096ec1b60aPharma Surgeen2026-06-18T13:10:13.000ZMemoria y compromiso a 11 años de Ni Una Menoshttps://www.pharmaradar360.com/article/perseverance-persistence-key-to-car-t-success-say-ross-prize-winners-carl-june-a-026b8e049ee6e550Pharma Surgeen2026-06-18T12:54:29.000ZPerseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelainhttps://www.pharmaradar360.com/article/hussman-alumna-hosts-fifa-world-cup-tv-series-3184d7fb2fc9898dPharma Surgeen2026-06-18T12:40:23.000ZHussman alumna hosts FIFA World Cup TV serieshttps://www.pharmaradar360.com/article/julie-enevold-brooker-oraz-gabor-sztaniszlav-zostali-wybrani-do-zarzadu-zwiazku-5f31c00ffd33c506Pharma Surgeen2026-06-18T12:31:05.000ZJulie Enevold Brooker oraz Gábor Sztaniszláv zostali wybrani do Zarządu Związku Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMAhttps://www.pharmaradar360.com/article/health-minister-apologises-for-nhse-error-on-fdp-data-access-27bb98c0badd3a3dPharma Surgeen2026-06-18T12:30:14.000ZHealth minister apologises for NHSE error on FDP data accesshttps://www.pharmaradar360.com/article/decision-orphan-registered-medicinal-products-0c37863c0511be51Pharma Surgeen2026-06-18T12:24:16.000ZDecision: Orphan registered medicinal productshttps://www.pharmaradar360.com/article/prac-8-11-2026-b6ce855fab005ce3Pharma Surgeen2026-06-18T12:23:06.000ZΚύρια σημεία συνεδρίασης της Επιτροπής Αξιολόγησης Κινδύνου Φαρμακοεπαγρύπνησης (PRAC), 8 – 11 Ιουνίου 2026https://www.pharmaradar360.com/article/ancient-dna-reveals-plague-was-already-killing-humans-5-500-years-ago-d8cbdc41a5f6b20bPharma Surgeen2026-06-18T12:16:46.000ZAncient DNA reveals plague was already killing humans 5,500 years agohttps://www.pharmaradar360.com/article/nirrin-technologies-and-s-t-japan-partner-on-next-gen-protein-quantitation-tech-7ef2a671e4afa0f5Pharma Surgeen2026-06-18T12:00:17.000ZNirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Techhttps://www.pharmaradar360.com/article/charles-river-joins-lilly-tunelab-to-optimize-ai-ml-platform-through-nonclinical-39298218e80e3690Pharma Surgeen2026-06-18T12:00:00.000ZCharles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertisehttps://www.pharmaradar360.com/article/leci-research-seminar-on-april-22nd-the-impact-of-the-use-of-digital-tools-outsi-fa6b61e131f5ac71Pharma Surgeen2026-06-18T11:45:10.000ZLECI Research Seminar on April 22nd: The impact of the use of digital tools outside schoolhttps://www.pharmaradar360.com/article/boston-researchers-land-9m-grant-to-advance-molecular-neuroimaging-b2161b0e065e58b2Pharma Surgeen2026-06-18T11:42:47.000ZBoston researchers land $9M grant to advance molecular neuroimaginghttps://www.pharmaradar360.com/article/coplant-studie-begru-t-3-000-teilnehmerin-in-heidelberg-dead22425a1e4809Pharma Surgeen2026-06-18T11:36:51.000ZCOPLANT-Studie begrüßt 3.000. Teilnehmerin in Heidelberghttps://www.pharmaradar360.com/article/leci-research-seminar-on-february-6th-flourishing-purpose-and-meaning-in-educati-6cb3f5d28fd58e6aPharma Surgeen2026-06-18T11:32:16.000ZLECI Research Seminar on February 6th: Flourishing, Purpose and Meaning in Educationhttps://www.pharmaradar360.com/article/tibsovo-a74376e454b023e8Pharma Surgeen2026-06-18T11:05:00.000ZTibsovohttps://www.pharmaradar360.com/article/eye-on-ai-agentic-ai-brings-bots-to-the-bench-f0091ca3eda01b21Pharma Surgeen2026-06-18T11:01:47.000ZEye on AI: Agentic AI Brings Bots to the Benchhttps://www.pharmaradar360.com/article/guidance-advice-for-consumers-5875243b09fda550Pharma Surgeen2026-06-18T11:01:43.000ZGuidance: Advice for consumershttps://www.pharmaradar360.com/article/fraunhofer-and-institut-mines-telecom-imt-to-strengthen-their-research-partnersh-54879f0b0fe92433Pharma Surgeen2026-06-18T11:00:00.000ZFraunhofer and Institut Mines Télécom (IMT) to Strengthen Their Research Partnershiphttps://www.pharmaradar360.com/article/bristol-myers-squibb-to-report-results-for-second-quarter-2026-on-july-30-2026-27fa87b42ec9f367Pharma Surgeen2026-06-18T10:59:00.000ZBristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026https://www.pharmaradar360.com/article/pfizer-hunts-for-new-cfo-as-denton-prepares-to-hang-up-gloves-wave-goodbye-to-ph-77406b48c56af5f9Pharma Surgeen2026-06-18T10:58:00.000ZPfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharmahttps://www.pharmaradar360.com/article/su-policy-innovation-lab-helps-equip-parliament-for-ai-1c4130f529e51dbfPharma Surgeen2026-06-18T10:52:01.000ZSU Policy Innovation Lab helps equip Parliament for AIhttps://www.pharmaradar360.com/article/u-s-fda-approves-an-additional-indication-for-capvaxive-pneumococcal-21-valent-c-5d4866f007690139Pharma Surgeen2026-06-18T10:45:00.000ZU.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Diseasehttps://www.pharmaradar360.com/article/listening-attentively-to-the-people-of-rotterdam-19d05e21080d0104Pharma Surgeen2026-06-18T10:45:00.000ZListening attentively to the people of Rotterdamhttps://www.pharmaradar360.com/article/ada26-retatrutide-delivers-unprecedented-weight-loss-in-phase-iii-triumph-1-5e83af8b8b064b62Pharma Surgeen2026-06-18T10:40:05.000ZADA26: retatrutide delivers unprecedented weight loss in Phase III TRIUMPH-1https://www.pharmaradar360.com/article/digital-health-coffee-time-briefing-7c5cfe9343da5b24Pharma Surgeen2026-06-18T10:30:22.000ZDigital Health Coffee Time Briefing ☕https://www.pharmaradar360.com/article/kemri-air-pollution-centre-of-excellence-attains-international-accreditation-c2a91da3b65e3193Pharma Surgeen2026-06-18T10:23:43.000ZKEMRI Air Pollution Centre of Excellence Attains International Accreditationhttps://www.pharmaradar360.com/article/kemri-management-staff-participate-in-east-africa-regional-conference-on-public-2a50e8d1c6eaf145Pharma Surgeen2026-06-18T10:19:45.000ZKEMRI Management Staff Participate in East Africa Regional Conference on Public Administration and Regional Integrationhttps://www.pharmaradar360.com/article/expanding-the-vaccine-landscape-with-new-technologies-q-a-with-silvia-taylor-fbc918283a77836dPharma Surgeen2026-06-18T10:00:00.000ZExpanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylorhttps://www.pharmaradar360.com/article/evolving-beyond-launch-postmortems-to-real-time-optimization-ba2420854a5c268dPharma Surgeen2026-06-18T10:00:00.000ZEvolving Beyond Launch Postmortems to Real-Time Optimizationhttps://www.pharmaradar360.com/article/how-is-boehringer-ingelheim-s-deliberate-glp-1-strategy-different-from-competito-bd9e20313bee1305Pharma Surgeen2026-06-18T10:00:00.000ZHow is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?https://www.pharmaradar360.com/article/campfield-harvests-180m-series-a-to-advance-oral-ibd-drug-licensed-from-newsoara-9a0e49af698f2735Pharma Surgeen2026-06-18T10:00:00.000ZcAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoarahttps://www.pharmaradar360.com/article/amid-industry-s-cell-therapy-automation-push-cellares-and-ori-dominate-the-field-14cb04962ea51f12Pharma Surgeen2026-06-18T09:52:00.000ZAmid industry’s cell therapy automation push, Cellares and Ori dominate the field: reporthttps://www.pharmaradar360.com/article/jazz-and-abcellera-sign-deal-for-t-cell-engagers-in-solid-tumours-64e293a0066e6f33Pharma Surgeen2026-06-18T09:33:13.000ZJazz and AbCellera sign deal for T-cell engagers in solid tumourshttps://www.pharmaradar360.com/article/lancement-du-projet-de-restructuration-de-la-pedopsychiatrie-aux-hopitaux-univer-b931192d09ba7b8ePharma Surgeen2026-06-18T09:32:56.000ZLancement du projet de restructuration de la pédopsychiatrie aux Hôpitaux Universitaires de Strasbourghttps://www.pharmaradar360.com/article/minimum-service-from-20-july-till-3-august-e5e7835bed7b9d32Pharma Surgeen2026-06-18T09:32:51.000ZMinimum service from 20 July till 3 Augusthttps://www.pharmaradar360.com/article/die-zukunft-der-psychotherapie-was-kann-kunstliche-intelligenz-und-was-nicht-e898b2b0594df5b9Pharma Surgeen2026-06-18T09:29:19.000ZDie Zukunft der Psychotherapie: Was kann künstliche Intelligenz – und was nicht?https://www.pharmaradar360.com/article/additional-parental-leave-most-popular-among-middle-income-groups-e5c5d30c29dafde8Pharma Surgeen2026-06-18T09:22:12.000ZAdditional parental leave most popular among middle-income groupshttps://www.pharmaradar360.com/article/phasewell-and-lctc-to-expand-clinical-trial-access-in-puerto-rico-0fae56d71937fca3Pharma Surgeen2026-06-18T09:20:09.000ZPhaseWell and LCTC to expand clinical trial access in Puerto Ricohttps://www.pharmaradar360.com/article/first-patient-dosed-in-deciphera-s-phase-iii-intrepid-study-307d5f7da8028fccPharma Surgeen2026-06-18T09:09:42.000ZFirst patient dosed in Deciphera’s Phase III INTREPID studyhttps://www.pharmaradar360.com/article/wuxi-biologics-suzhou-biosafety-testing-center-received-fourth-ema-gmp-certifica-173ab8edfa413802Pharma Surgeen2026-06-18T09:06:33.000ZWuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Markethttps://www.pharmaradar360.com/article/lg-ai-research-and-d-d-pharmatech-sign-agreement-for-oral-peptide-drugs-b5c2ef9097d8b441Pharma Surgeen2026-06-18T09:04:38.000ZLG AI Research and D&D Pharmatech sign agreement for oral peptide drugshttps://www.pharmaradar360.com/article/sk-pharmteco-announces-strategic-collaboration-with-orphan-therapeutics-accelera-6c12379e313f06bbPharma Surgeen2026-06-18T09:01:00.000ZSK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapieshttps://www.pharmaradar360.com/article/suburban-woman-reclaims-her-voice-with-help-from-the-northwestern-medicine-aphas-67cf5c2b4fbe49b7Pharma Surgeen2026-06-18T09:00:00.000ZSuburban Woman Reclaims Her Voice with Help from the Northwestern Medicine Aphasia Center at Marianjoy Rehabilitation Hospitalhttps://www.pharmaradar360.com/article/call-for-the-eur-erasmus-mc-open-and-responsible-science-awards-2026-79890feb3d4983a8Pharma Surgeen2026-06-18T08:55:00.000ZCall for the EUR / Erasmus MC Open and Responsible Science Awards 2026https://www.pharmaradar360.com/article/kemri-delegation-returns-from-china-with-lessons-for-strengthening-kenya-s-publi-0f6236baba17fcb8Pharma Surgeen2026-06-18T08:47:35.000ZKEMRI delegation returns from China with Lessons for Strengthening Kenya’s Public Health Architecturehttps://www.pharmaradar360.com/article/novo-s-success-with-oral-wegovy-has-been-fueled-by-familiarity-spherix-6b902682808f2b19Pharma Surgeen2026-06-18T08:47:00.000ZNovo's success with oral Wegovy has been fueled by 'familiarity': Spherixhttps://www.pharmaradar360.com/article/the-teacher-of-field-courses-guides-students-into-practical-work-life-b3a976839c5698c8Pharma Surgeen2026-06-18T08:45:02.000ZThe teacher of field courses guides students into practical work lifehttps://www.pharmaradar360.com/article/complementing-depmap-expanding-the-toolkit-for-oncology-target-discovery-and-de-dddb0a179482486dPharma Surgeen2026-06-18T08:42:10.000ZComplementing DepMap: Expanding the toolkit for oncology target discovery and de-riskinghttps://www.pharmaradar360.com/article/epicur-lecture-series-on-dignity-at-the-end-of-life-da6047ad2b79dd7fPharma Surgeen2026-06-18T08:40:22.000ZEPICUR Lecture Series on Dignity at the End of Lifehttps://www.pharmaradar360.com/article/advancing-care-in-renal-cell-carcinoma-earlier-treatment-better-outcomes-and-str-0ef9d29c0a73e047Pharma Surgeen2026-06-18T08:37:09.000ZAdvancing Care in Renal Cell Carcinoma: Earlier Treatment, Better Outcomes, and Stronger Support for Patientshttps://www.pharmaradar360.com/article/pharmaceutical-innovation-key-to-delivering-g7-leaders-growth-agenda-828a8c96643de13dPharma Surgeen2026-06-18T08:31:24.000ZPharmaceutical innovation key to delivering G7 leaders’ growth agendahttps://www.pharmaradar360.com/article/su-again-ranked-among-top-universities-in-the-world-353aa269beb374a9Pharma Surgeen2026-06-18T08:15:55.000ZSU again ranked among top universities in the worldhttps://www.pharmaradar360.com/article/new-data-shows-the-hpv-vaccine-is-saving-lives-from-cervical-cancer-ddb4f6ac7fad5288Pharma Surgeen2026-06-18T08:10:21.000ZNew data shows the HPV vaccine is saving lives from cervical cancerhttps://www.pharmaradar360.com/article/bbsrc-invests-in-21-new-fellows-211d3084d93139eePharma Surgeen2026-06-18T08:00:45.000ZBBSRC invests in 21 new Fellowshttps://www.pharmaradar360.com/article/chronische-darmbeschwerden-von-der-diagnose-zur-modernen-therapie-fba22ef8c4d7cce6Pharma Surgeen2026-06-18T07:56:00.000ZChronische Darmbeschwerden: Von der Diagnose zur modernen Therapiehttps://www.pharmaradar360.com/article/kardigan-buttons-up-400m-upsized-ipo-to-power-heart-drugs-toward-phase-3-06ef772f8a1c0858Pharma Surgeen2026-06-18T07:29:00.000ZKardigan buttons up $400M upsized IPO to power heart drugs toward phase 3https://www.pharmaradar360.com/article/avacta-academy-episode-3-8f9c5fa7d5cc0efdPharma Surgeen2026-06-18T07:28:37.000ZAvacta Academy – Episode 3https://www.pharmaradar360.com/article/novocure-device-fails-to-improve-brain-cancer-patients-survival-in-phase-3-test-f613077ec17433f8Pharma Surgeen2026-06-18T07:24:00.000ZNovocure device fails to improve brain cancer patients’ survival in phase 3 testhttps://www.pharmaradar360.com/article/een-sterke-biofarmaceutische-sector-in-ons-land-draagt-bij-aan-de-welvaart-en-he-3bf8628d11f42caePharma Surgeen2026-06-18T07:05:16.000ZEen sterke biofarmaceutische sector in ons land draagt bij aan de welvaart en het welzijn van velenhttps://www.pharmaradar360.com/article/marlon-tobaben-vaittelee-aiheesta-tietosuoja-datatehokkaassa-syvaoppimisessa-11164008cb0642adPharma Surgeen2026-06-18T07:03:28.000ZMarlon Tobaben väittelee aiheesta Tietosuoja datatehokkaassa syväoppimisessahttps://www.pharmaradar360.com/article/strategic-autonomy-requires-tailored-policies-by-region-and-sector-3c30c5ecc46e8850Pharma Surgeen2026-06-18T07:00:57.000ZStrategic autonomy requires tailored policies by region and sectorhttps://www.pharmaradar360.com/article/wildfire-rapid-needs-assessment-will-help-communities-recover-and-prepare-4aa1e59fb99939f4Pharma Surgeen2026-06-18T07:00:00.000ZWildfire Rapid Needs Assessment will help communities recover and preparehttps://www.pharmaradar360.com/article/we-are-embl-alana-sousa-on-data-and-machine-learning-from-young-stars-to-crystal-c40c5b26e4712f7ePharma Surgeen2026-06-18T07:00:00.000ZWe are EMBL: Alana Sousa on data and machine learning, from young stars to crystalshttps://www.pharmaradar360.com/article/water-saving-measures-at-the-cek-reduce-water-consumption-by-nearly-800-000-litr-4bedaf6fd649fe89Pharma Surgeen2026-06-18T07:00:00.000ZWater-saving measures at the CEK reduce water consumption by nearly 800,000 litres in one yearhttps://www.pharmaradar360.com/article/delivering-better-care-for-premature-infants-with-bronchopulmonary-dysplasia-41dd45cc149e6fe6Pharma Surgeen2026-06-18T07:00:00.000ZDelivering better care for premature infants with bronchopulmonary dysplasiahttps://www.pharmaradar360.com/article/i-can-be-myself-in-a-small-town-b9bdb8b9636a8f35Pharma Surgeen2026-06-18T06:58:00.000Z‘I can be myself in a small town’https://www.pharmaradar360.com/article/rheumatology-services-now-offered-at-sharing-clinic-5763aae021cf21d1Pharma Surgeen2026-06-18T06:56:00.000ZRheumatology services now offered at SHARING Clinichttps://www.pharmaradar360.com/article/die-situation-nicht-verwandter-zugehoriger-verstehen-82f0bc46ec0a5779Pharma Surgeen2026-06-18T06:36:02.000ZDie Situation nicht verwandter Zugehöriger verstehenhttps://www.pharmaradar360.com/article/university-hospitals-sussex-eds-switch-to-digital-observations-74ca6c1d75546440Pharma Surgeen2026-06-18T06:30:28.000ZUniversity Hospitals Sussex EDs switch to digital observationshttps://www.pharmaradar360.com/article/training-exercise-at-mri-bf5b357780bd046dPharma Surgeen2026-06-18T06:00:15.000ZTraining exercise at MRIhttps://www.pharmaradar360.com/article/comment-ameliorer-la-sante-mentale-des-agriculteurs-f7d7d727247860caPharma Surgeen2026-06-18T06:00:00.000ZComment améliorer la santé mentale des agriculteurs ?https://www.pharmaradar360.com/article/rna-seq-5674f3b6a8235a7ePharma Surgeen2026-06-18T05:21:47.000Z老化・慢性疾患・若返りに共通する 「死亡リスクを推定する指標」を開発 － RNA-seqデータから加齢を測定 －https://www.pharmaradar360.com/article/researchers-found-8-common-food-additives-linked-to-high-blood-pressure-and-hear-b330dd2017148883Pharma Surgeen2026-06-18T05:21:12.000ZResearchers found 8 common food additives linked to high blood pressure and heart diseasehttps://www.pharmaradar360.com/article/ai-readiness-in-pharma-getting-the-foundation-right-3134cf18fd68bcb2Pharma Surgeen2026-06-18T05:01:01.000ZAI Readiness in Pharma – Getting the Foundation Righthttps://www.pharmaradar360.com/article/fda-accepts-supplemental-biologics-license-application-for-roche-s-lunsumio-and-fa7206025be74ee2Pharma Surgeen2026-06-18T05:00:00.000ZFDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphomahttps://www.pharmaradar360.com/article/biogen-inks-1b-raythera-buyout-to-bag-preclinical-immunology-assets-7e95ff816e5572f4Pharma Surgeen2026-06-18T04:10:00.000ZBiogen inks $1B RayThera buyout to bag preclinical immunology assetshttps://www.pharmaradar360.com/article/cual-es-el-impacto-de-la-digitalizacion-en-el-desarrollo-infantil-a37a952f0b634e8fPharma Surgeen2026-06-18T01:34:34.000Z¿Cuál es el impacto de la digitalización en el desarrollo infantil?https://www.pharmaradar360.com/article/the-future-of-tertiary-lymphoid-structures-in-cancer-immunotherapy-as-biomarkers-c9f74241988b3d00Pharma Surgeen2026-06-18T00:00:00.000ZThe future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targetshttps://www.pharmaradar360.com/article/daily-briefing-the-proteins-that-protect-us-from-deadly-mutations-79a53e3ffe61a73cPharma Surgeen2026-06-18T00:00:00.000ZDaily briefing: The proteins that protect us from deadly mutationshttps://www.pharmaradar360.com/article/is-ai-ruining-our-skills-early-results-are-in-and-they-re-not-good-a459f71d56c6088cPharma Surgeen2026-06-18T00:00:00.000ZIs AI ruining our skills? Early results are in — and they’re not goodhttps://www.pharmaradar360.com/article/cell-transplant-across-the-tree-of-life-hints-at-how-animals-emerged-0f19f8feb6d4c8a0Pharma Surgeen2026-06-18T00:00:00.000ZCell transplant across the tree of life hints at how animals emergedhttps://www.pharmaradar360.com/article/it-slices-it-dices-sashimi-bot-handles-seafood-with-ease-14369099b98131bdPharma Surgeen2026-06-18T00:00:00.000ZIt slices! It dices! Sashimi-Bot handles seafood with easehttps://www.pharmaradar360.com/article/clues-to-the-sloth-s-sloth-found-in-its-genome-273fce3c723ac6f1Pharma Surgeen2026-06-18T00:00:00.000ZClues to the sloth’s sloth found in its genomehttps://www.pharmaradar360.com/article/brexit-tore-apart-european-science-now-the-research-rifts-are-healing-feddc3c416762e84Pharma Surgeen2026-06-18T00:00:00.000ZBrexit tore apart European science — now the research rifts are healinghttps://www.pharmaradar360.com/article/multispecific-t-cell-engagers-attract-cancer-drug-developers-08aecb9f2559c4e7Pharma Surgeen2026-06-18T00:00:00.000ZMultispecific T-cell engagers attract cancer drug developershttps://www.pharmaradar360.com/article/can-multispecific-biologics-break-the-efficacy-ceiling-94847d0a10ab33ebPharma Surgeen2026-06-18T00:00:00.000ZCan multispecific biologics break the efficacy ceiling?https://www.pharmaradar360.com/article/new-antibiotic-targets-novel-ribosomal-site-9c9fa1e3c76277dfPharma Surgeen2026-06-18T00:00:00.000ZNew antibiotic targets novel ribosomal sitehttps://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-1800ffc1b0ce3221Pharma Surgeen2026-06-18T00:00:00.000Znatco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-c11712334ce2fc76Pharma Surgeen2026-06-18T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b91463-crore-consolidated-revenue-and-e2-82-b9517-9-crore-of-ed9c868b45898909Pharma Surgeen2026-06-18T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-9520c4c6b022f842Pharma Surgeen2026-06-18T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-b7b24e47bad5c1bcPharma Surgeen2026-06-18T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-bc8da7271e4fe219Pharma Surgeen2026-06-18T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-f8f4eb040b22d0f1Pharma Surgeen2026-06-18T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-14adab382ddd6641Pharma Surgeen2026-06-18T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/natco-announces-launch-of-its-everolimus-tablets-1-mg-generic-of-zortress-e3181ace90530433Pharma Surgeen2026-06-18T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-d6991f1c7e145f0aPharma Surgeen2026-06-18T00:00:00.000Znatco and lupin receive approval from u s fda for eribulin mesylate injectionhttps://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-c5ba64e9daf2c7e4Pharma Surgeen2026-06-18T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-eec99e83bda96a8dPharma Surgeen2026-06-18T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/adcock-ingram-completes-delisting-from-jse-natco-pharma-acquires-35-75-stake-5059191f757f5ae7Pharma Surgeen2026-06-18T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/home-page-db2f229192075afePharma Surgeen2026-06-18T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/what-are-hfpef-mimics-and-what-are-they-mimicking-insights-into-our-conceptualiz-595ffd6cc745141bPharma Surgeen2026-06-18T00:00:00.000ZWhat Are HFpEF Mimics and What Are They Mimicking? Insights Into Our Conceptualization of Heart Failure With Preserved Ejection Fraction as a Diseasehttps://www.pharmaradar360.com/article/tre-bitradande-lektorer-vid-ki-far-finansiering-fran-vetenskapsradet-c8689f9e20d904a4Pharma Surgeen2026-06-18T00:00:00.000ZTre biträdande lektorer vid KI får finansiering från Vetenskapsrådethttps://www.pharmaradar360.com/article/mottagare-av-cimed-projektbidrag-2027-2029-vid-medh-c8c6ef2cbe8d6a4ePharma Surgeen2026-06-18T00:00:00.000ZMottagare av CIMED projektbidrag 2027-2029 vid MedHhttps://www.pharmaradar360.com/article/mottagare-av-cimed-projektbidrag-2027-2029-7345ac643192c624Pharma Surgeen2026-06-18T00:00:00.000ZMottagare av CIMED projektbidrag 2027-2029https://www.pharmaradar360.com/article/labmed-inrattar-centrum-for-systeminfektionsbiologi-csib-1c25bbe3a2041addPharma Surgeen2026-06-18T00:00:00.000ZLabmed inrättar centrum för systeminfektionsbiologi (CSIB)https://www.pharmaradar360.com/article/uc-y-clear-lac-fortalecen-colaboracion-con-republica-dominicana-en-monitoreo-y-e-4986ee8db2070bfcPharma Surgeen2026-06-17T23:40:44.000ZUC y CLEAR-LAC fortalecen colaboración con República Dominicana en monitoreo y evaluaciónhttps://www.pharmaradar360.com/article/patient-recruitment-and-community-engagement-issues-in-the-spotlight-from-acrp-2-1f141b7edd906d3ePharma Surgeen2026-06-17T23:30:34.000ZPatient Recruitment and Community Engagement Issues in the Spotlight from ACRP 2026https://www.pharmaradar360.com/article/qs-ranks-mit-the-world-s-no-1-university-for-2026-27-6c1a04d2ebb66291Pharma Surgeen2026-06-17T23:01:00.000ZQS ranks MIT the world’s No. 1 university for 2026-27https://www.pharmaradar360.com/article/ancc-magnet-recognition-program-site-visit-7e8555d344655d80Pharma Surgeen2026-06-17T22:52:14.000ZANCC Magnet Recognition Program Site Visithttps://www.pharmaradar360.com/article/2026-world-food-safety-day-capacity-building-event-for-nafdac-officers-67b01e127316e791Pharma Surgeen2026-06-17T22:30:31.000Z2026 World Food Safety Day Capacity Building Event For NAFDAC Officershttps://www.pharmaradar360.com/article/museu-da-computacao-e-reinaugurado-e-amplia-preservacao-da-memoria-da-informatic-247c12c4c0d1a822Pharma Surgeen2026-06-17T22:12:58.000ZMuseu da Computação é reinaugurado e amplia preservação da memória da informática brasileirahttps://www.pharmaradar360.com/article/a-look-at-the-state-of-healthcare-quality-measurement-programs-48534c6fc602e9bdPharma Surgeen2026-06-17T21:56:27.000ZA Look at the State of Healthcare Quality Measurement Programshttps://www.pharmaradar360.com/article/vitamin-d-benefits-food-sources-deficiency-signs-and-daily-recommendations-99c3eb4afe0353f6Pharma Surgeen2026-06-17T21:35:31.000ZVitamin D: Benefits, Food Sources, Deficiency Signs and Daily Recommendationshttps://www.pharmaradar360.com/article/one-medical-seniors-reports-data-breach-of-third-party-vendor-impacting-limited-cc9f635a946e498bPharma Surgeen2026-06-17T21:32:00.000ZOne Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patientshttps://www.pharmaradar360.com/article/a-woodbury-man-s-race-to-survive-after-cardiac-arrest-2f78b047d9f60ea3Pharma Surgeen2026-06-17T20:59:22.000ZA Woodbury man's race to survive after cardiac arresthttps://www.pharmaradar360.com/article/staggered-by-covid-st-paul-bets-big-on-creating-a-new-downtown-6242b517804cddb7Pharma Surgeen2026-06-17T20:58:55.000ZStaggered by COVID, St. Paul bets big on ‘creating a new downtown’https://www.pharmaradar360.com/article/minnesota-cities-are-trying-to-decode-data-center-impacts-06c8d9abfbdcddcePharma Surgeen2026-06-17T20:58:26.000ZMinnesota cities are trying to decode data center impactshttps://www.pharmaradar360.com/article/africa-conquista-conta-institucional-da-ems-1570650e01b61df8Pharma Surgeen2026-06-17T20:56:18.000ZÁfrica conquista conta institucional da EMShttps://www.pharmaradar360.com/article/lacday-long-action-produto-inedito-no-brasil-chega-ao-mercado-com-campanha-sobre-620f3535177c470bPharma Surgeen2026-06-17T20:37:26.000ZLacday Long Action: produto inédito no Brasil chega ao mercado com campanha sobre liberdade alimentar e transforma inovação em experiência realhttps://www.pharmaradar360.com/article/bristol-myers-squibb-announces-dividend-018ae6e68b74a970Pharma Surgeen2026-06-17T20:16:00.000ZBristol Myers Squibb Announces Dividendhttps://www.pharmaradar360.com/article/exozymes-inc-announces-closing-of-6-million-public-offering-5f32dd0fb916650bPharma Surgeen2026-06-17T20:10:02.000ZeXoZymes Inc. Announces Closing of $6 Million Public Offeringhttps://www.pharmaradar360.com/article/siemens-healthineers-invests-30m-into-new-radiopharmaceutical-facility-ac7679759bbdbcb3Pharma Surgeen2026-06-17T19:28:08.000ZSiemens Healthineers invests $30M into new radiopharmaceutical facilityhttps://www.pharmaradar360.com/article/personalized-cartilage-graft-developed-for-life-threatening-infant-airway-narrow-fc3afdd744477d94Pharma Surgeen2026-06-17T19:23:08.000ZPersonalized Cartilage Graft Developed for Life-Threatening Infant Airway Narrowinghttps://www.pharmaradar360.com/article/multimix-anuncia-promocao-inspirada-no-live-action-de-moana-dc942b6e9abf7a07Pharma Surgeen2026-06-17T19:09:07.000ZMultiMix anuncia promoção inspirada no live-action de Moanahttps://www.pharmaradar360.com/article/mirando-reforcar-sua-atuacao-grupo-nc-se-torna-grupo-ems-563e11439615b6bdPharma Surgeen2026-06-17T18:55:18.000ZMirando reforçar sua atuação, Grupo NC se torna Grupo EMShttps://www.pharmaradar360.com/article/radiologist-saw-signs-of-in-house-abuse-in-nicu-but-hospital-failed-to-act-on-hi-76aa0d0d40eb5298Pharma Surgeen2026-06-17T18:40:41.000ZRadiologist saw signs of in-house abuse in NICU, but hospital failed to act on his warninghttps://www.pharmaradar360.com/article/quantifying-the-true-value-of-ai-driven-in-silico-trials-6af6c4799fbe8121Pharma Surgeen2026-06-17T17:23:43.000ZQuantifying the true value of AI-driven in silico trialshttps://www.pharmaradar360.com/article/quantum-experiment-opens-gravitational-waves-and-dark-matter-search-b5c286c2228d36fdPharma Surgeen2026-06-17T17:21:16.000ZQuantum experiment opens gravitational waves and dark matter searchhttps://www.pharmaradar360.com/article/pharmaceutical-executive-daily-meaningfully-improving-therapy-persistence-in-pat-b68fbf2cc8aa6111Pharma Surgeen2026-06-17T17:07:37.000ZPharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programshttps://www.pharmaradar360.com/article/surging-impact-factors-mark-winning-year-for-esr-journals-5dbbca86a245f7a6Pharma Surgeen2026-06-17T17:02:58.000ZSurging Impact Factors mark winning year for ESR Journalshttps://www.pharmaradar360.com/article/happy-trails-to-chief-griffin-8fbf9821cdd69e1aPharma Surgeen2026-06-17T16:55:29.000ZHappy trails to Chief Griffinhttps://www.pharmaradar360.com/article/spreadsheets-vs-edc-real-cost-comparison-for-medtech-clinical-studies-63da89510e90dd5fPharma Surgeen2026-06-17T16:34:55.000ZSpreadsheets vs EDC: Real Cost Comparison for MedTech Clinical Studieshttps://www.pharmaradar360.com/article/verastem-oncology-s-pancreatic-cancer-combo-shows-86-os-rate-26540e5e2ee9e6e2Pharma Surgeen2026-06-17T16:29:21.000ZVerastem Oncology’s pancreatic cancer combo shows 86% OS ratehttps://www.pharmaradar360.com/article/biopharma-bounces-back-as-m-a-impetus-fuels-recovery-ba81ea3849461329Pharma Surgeen2026-06-17T16:17:20.000ZBiopharma bounces back as M&A impetus fuels recoveryhttps://www.pharmaradar360.com/article/migrating-to-chemaxon-java-libraries-26-what-changed-and-how-to-adapt-e06813d08e8a871ePharma Surgeen2026-06-17T16:07:34.000ZMigrating to Chemaxon Java Libraries 26: What Changed and How to Adapthttps://www.pharmaradar360.com/article/analytics-map-purification-optimization-tradeoffs-36c6d7a592af5942Pharma Surgeen2026-06-17T16:00:59.000ZAnalytics Map Purification Optimization Tradeoffshttps://www.pharmaradar360.com/article/continuous-production-platform-offers-new-gene-therapy-options-f5974a53d54e7f98Pharma Surgeen2026-06-17T16:00:47.000ZContinuous Production Platform Offers New Gene Therapy Optionshttps://www.pharmaradar360.com/article/bacterial-expression-tech-prompts-northx-and-engenes-collaboration-bfdf4ddea4cc61edPharma Surgeen2026-06-17T16:00:34.000ZBacterial Expression Tech Prompts NorthX and enGenes Collaborationhttps://www.pharmaradar360.com/article/solvent-recovery-gains-ground-in-bioprocessing-1fff8ff6eb1c7a66Pharma Surgeen2026-06-17T16:00:23.000ZSolvent Recovery Gains Ground in Bioprocessinghttps://www.pharmaradar360.com/article/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary-acb5e3613f289077Pharma Surgeen2026-06-17T16:00:00.000ZUtebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)https://www.pharmaradar360.com/article/rx-tariff-just-around-the-corner-1276468dd3af75aaPharma Surgeen2026-06-17T16:00:00.000ZRx tariff just around the cornerhttps://www.pharmaradar360.com/article/private-equity-in-healthcare-after-connecticut-why-the-life-sciences-industry-ne-04990d13fef1ed17Pharma Surgeen2026-06-17T15:56:57.000ZPrivate Equity in Healthcare After Connecticut: Why the Life Sciences Industry Needs Stewardship Capital, Not Financial Engineeringhttps://www.pharmaradar360.com/article/meet-ismael-using-his-voice-for-change-and-a-better-future-af8f8a05a892d754Pharma Surgeen2026-06-17T15:51:30.000ZMeet Ismael: Using His Voice for Change and a Better Futurehttps://www.pharmaradar360.com/article/circle-lancement-officiel-du-nouveau-centre-d-excellence-pour-la-recherche-en-ca-b280b6442073a482Pharma Surgeen2026-06-17T15:50:09.000ZCIRCLE : lancement officiel du nouveau centre d'excellence pour la recherche en cancérologie pédiatriquehttps://www.pharmaradar360.com/article/vedana-debuts-with-46m-to-progress-migraine-therapies-dfaeff12cb6103d7Pharma Surgeen2026-06-17T15:39:52.000ZVedana debuts with $46m to progress migraine therapieshttps://www.pharmaradar360.com/article/jornada-de-donacion-de-sangre-8ae3c9523f813272Pharma Surgeen2026-06-17T15:29:35.000ZJornada de donación de sangrehttps://www.pharmaradar360.com/article/ohiohealth-reaches-settlement-with-doj-ohio-ag-on-antitrust-lawsuit-1608384976d37441Pharma Surgeen2026-06-17T15:04:00.000ZOhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuithttps://www.pharmaradar360.com/article/element-biosciences-achieves-iso-13485-certification-establishing-quality-founda-ba480329347f0a9dPharma Surgeen2026-06-17T15:03:29.000ZElement Biosciences Achieves ISO 13485 Certification, Establishing Quality Foundation for Forthcoming Diagnostic Applicationshttps://www.pharmaradar360.com/article/ki-agent-mira-unterstutzt-als-co-pilot-klinische-ablaufe-in-elektronischen-patie-aa27b166af07deebPharma Surgeen2026-06-17T15:01:38.000ZKI-Agent MIRA unterstützt als Co-Pilot klinische Abläufe in elektronischen Patientenaktenhttps://www.pharmaradar360.com/article/tecnologia-3d-el-plan-de-la-unlp-y-la-provincia-contra-la-crisis-habitacional-f4702b98c67a8624Pharma Surgeen2026-06-17T15:00:41.000ZTecnología 3D: el plan de la UNLP y la Provincia contra la crisis habitacionalhttps://www.pharmaradar360.com/article/la-unlp-en-un-relevamiento-inedito-en-barrios-populares-de-la-plata-berisso-y-en-40319831192f5decPharma Surgeen2026-06-17T15:00:11.000ZLa UNLP en un relevamiento inédito en barrios populares de La Plata, Berisso y Ensenadahttps://www.pharmaradar360.com/article/riken-co-hosts-electron-ion-collider-resource-review-board-cd792adf9244b3d2Pharma Surgeen2026-06-17T15:00:00.000ZRIKEN co-hosts Electron Ion Collider Resource Review Boardhttps://www.pharmaradar360.com/article/oldest-strains-of-plague-caused-deadly-outbreaks-5-500-years-ago-7fb592279c9fc465Pharma Surgeen2026-06-17T15:00:00.000ZOldest strains of plague caused deadly outbreaks 5,500 years agohttps://www.pharmaradar360.com/article/4-years-after-snub-gsk-partnership-helps-spero-get-utebzi-across-fda-finish-line-7896286ebee0875dPharma Surgeen2026-06-17T14:55:00.000Z4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish linehttps://www.pharmaradar360.com/article/addressing-access-and-equity-in-sickle-cell-disease-care-afffbaca0fe59148Pharma Surgeen2026-06-17T14:50:00.000ZAddressing access and equity in sickle cell disease carehttps://www.pharmaradar360.com/article/despite-decent-data-verastem-rethinks-options-for-approved-oncology-combo-in-pan-c55c682f1341ad60Pharma Surgeen2026-06-17T14:46:00.000ZDespite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancerhttps://www.pharmaradar360.com/article/f2g-shionogi-prep-regulatory-push-after-novel-antifungal-passes-ph-3-test-9f001c5ebbf16d88Pharma Surgeen2026-06-17T14:36:00.000ZF2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 testhttps://www.pharmaradar360.com/article/3-fragen-an-unser-neues-boardmitglied-rea-lal-country-lead-von-pfizer-switzerlan-d2c6d729ce73fb12Pharma Surgeen2026-06-17T14:35:20.000Z3 Fragen an unser neues Boardmitglied: Rea Lal, Country Lead von Pfizer Switzerlandhttps://www.pharmaradar360.com/article/humans-may-have-hidden-regenerative-powers-681b3ce9b579ac2ePharma Surgeen2026-06-17T14:25:31.000ZHumans may have hidden regenerative powershttps://www.pharmaradar360.com/article/aceite-vegetal-usado-avu-07c1f0ed611f4d77Pharma Surgeen2026-06-17T14:20:15.000ZAceite Vegetal Usado (AVU)https://www.pharmaradar360.com/article/catedras-libres-30ec28ca651c9366Pharma Surgeen2026-06-17T14:19:42.000ZCátedras Libreshttps://www.pharmaradar360.com/article/fda-files-concerns-over-missing-data-for-moderna-s-mrna-flu-shot-report-37e54c48c40fbc55Pharma Surgeen2026-06-17T14:19:00.000ZFDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Reporthttps://www.pharmaradar360.com/article/subsidios-a-reuniones-cientificas-con-sede-en-la-unlp-2026-e795cc21f30fe18fPharma Surgeen2026-06-17T14:14:43.000ZSubsidios a Reuniones Científicas con Sede en la UNLP 2026https://www.pharmaradar360.com/article/6-7-million-global-award-to-prevent-cardiovascular-disease-60782ce19f0e1fc1Pharma Surgeen2026-06-17T14:00:00.000Z£6.7 million global award to prevent cardiovascular diseasehttps://www.pharmaradar360.com/article/local-healthcare-executive-to-lead-2026-kern-county-heart-and-stroke-walk-and-co-987ae5984b0ad814Pharma Surgeen2026-06-17T14:00:00.000ZLocal healthcare executive to lead 2026 Kern County Heart and Stroke Walk and county-wide push for CPR readinesshttps://www.pharmaradar360.com/article/local-executives-to-lead-2026-washington-heart-and-stroke-walk-and-push-for-cpr-e5e0808599033bd3Pharma Surgeen2026-06-17T14:00:00.000ZLocal executives to lead 2026 Washington Heart and Stroke Walk and push for CPR readinesshttps://www.pharmaradar360.com/article/the-fungal-blind-spot-why-marine-carbon-models-ignore-a-key-player-0897517c68afe8b8Pharma Surgeen2026-06-17T14:00:00.000ZThe fungal blind spot: Why marine carbon models ignore a key playerhttps://www.pharmaradar360.com/article/su-and-tut-join-forces-to-develop-sa-s-future-research-leaders-163aa79ef3225d19Pharma Surgeen2026-06-17T13:55:01.000ZSU and TUT join forces to develop SA’s future research leadershttps://www.pharmaradar360.com/article/cough-cold-2f010b70e13c5674Pharma Surgeen2026-06-17T13:47:33.000ZCough & coldhttps://www.pharmaradar360.com/article/pain-management-bc69aa8191f25f12Pharma Surgeen2026-06-17T13:47:33.000ZPain managementhttps://www.pharmaradar360.com/article/neurology-18917d852793fb1ePharma Surgeen2026-06-17T13:47:33.000ZNeurologyhttps://www.pharmaradar360.com/article/cardiometabolic-8a38b7bf84a7d94aPharma Surgeen2026-06-17T13:47:33.000ZCardiometabolichttps://www.pharmaradar360.com/article/intim-health-b1a43795f16b64dfPharma Surgeen2026-06-17T13:47:33.000ZIntim healthhttps://www.pharmaradar360.com/article/gastroenterology-753abc0c388b7e33Pharma Surgeen2026-06-17T13:47:33.000ZGastroenterologyhttps://www.pharmaradar360.com/article/skin-care-ed148fe3816b5140Pharma Surgeen2026-06-17T13:47:33.000ZSkin carehttps://www.pharmaradar360.com/article/antibiotics-and-antiseptics-e5d0bd03446cfa97Pharma Surgeen2026-06-17T13:47:33.000ZAntibiotics and antisepticshttps://www.pharmaradar360.com/article/drugs-for-allergy-ee8e6255d2e75650Pharma Surgeen2026-06-17T13:47:33.000ZDrugs for Allergyhttps://www.pharmaradar360.com/article/3e7b7a14b7de42adPharma Surgeen2026-06-17T13:47:33.000ZПрепарати від застуди та температуриhttps://www.pharmaradar360.com/article/357ac1c61a0452abPharma Surgeen2026-06-17T13:47:33.000ZПрепарати від болю та запаленняhttps://www.pharmaradar360.com/article/f999c961a3fe8118Pharma Surgeen2026-06-17T13:47:33.000ZНеврологічні препаратиhttps://www.pharmaradar360.com/article/6a48f093dfbd129fPharma Surgeen2026-06-17T13:47:33.000ZКардіометаболічні препаратиhttps://www.pharmaradar360.com/article/d56370f53c72afe2Pharma Surgeen2026-06-17T13:47:33.000ZПрепарати для інтимного здоров'яhttps://www.pharmaradar360.com/article/e251bf5640aabdd1Pharma Surgeen2026-06-17T13:47:33.000ZПрепарати для застосування у хірургіїhttps://www.pharmaradar360.com/article/4efa39be90d25336Pharma Surgeen2026-06-17T13:47:33.000ZГастроентерологічні препаратиhttps://www.pharmaradar360.com/article/a00f060a1d0b67aePharma Surgeen2026-06-17T13:47:33.000ZДерматологічні препаратиhttps://www.pharmaradar360.com/article/7f32db69f90c1f73Pharma Surgeen2026-06-17T13:47:33.000ZАнтибактеріальні препарати та антисептикиhttps://www.pharmaradar360.com/article/81cb782ffecd1900Pharma Surgeen2026-06-17T13:47:33.000ZПрепарати при алергіїhttps://www.pharmaradar360.com/article/f5a65b32542ef629Pharma Surgeen2026-06-17T13:47:33.000ZПрепаратиhttps://www.pharmaradar360.com/article/age-related-inflammation-linked-to-r-loop-nucleic-acids-opens-therapies-b841f510e6e7ec14Pharma Surgeen2026-06-17T13:45:25.000ZAge-Related Inflammation Linked to R-Loop Nucleic Acids, Opens Therapieshttps://www.pharmaradar360.com/article/magical-artifact-heidelberg-researchers-decipher-ancient-curse-tablet-5777503708e4423bPharma Surgeen2026-06-17T13:40:45.000Z“Magical” Artifact: Heidelberg Researchers Decipher Ancient Curse Tablethttps://www.pharmaradar360.com/article/oig-report-raises-red-flags-about-maternal-health-ghost-networks-in-medicaid-man-ff74858b22012523Pharma Surgeen2026-06-17T13:37:00.000ZOIG report raises red flags about maternal health 'ghost networks' in Medicaid managed carehttps://www.pharmaradar360.com/article/pharma-m-a-roundup-protillion-biosciences-enters-drug-discovery-collaboration-wi-42eb4de2fcd6725ePharma Surgeen2026-06-17T13:31:51.000ZPharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmaceuticals and AbCellera Enter Collaborationhttps://www.pharmaradar360.com/article/triveni-bio-raises-65m-ahead-of-upcoming-readouts-on-eczema-drugs-939020fe1af74740Pharma Surgeen2026-06-17T13:29:08.000ZTriveni Bio raises $65M ahead of upcoming readouts on eczema drugshttps://www.pharmaradar360.com/article/lantern-marathon-health-team-up-to-launch-integrated-care-management-model-f1d2749a792d6bfcPharma Surgeen2026-06-17T13:20:00.000ZLantern, Marathon Health team up to launch integrated care management modelhttps://www.pharmaradar360.com/article/transferencia-a-municipios-facultad-de-ciencias-agrarias-y-forestales-697ebc3919ff235dPharma Surgeen2026-06-17T13:18:55.000ZTransferencia a Municipios — Facultad de Ciencias Agrarias y Forestaleshttps://www.pharmaradar360.com/article/five-takeaways-from-the-first-european-conference-on-sex-differences-fcdac10a6218490dPharma Surgeen2026-06-17T13:05:39.000ZFive takeaways from the first European conference on sex differenceshttps://www.pharmaradar360.com/article/eight-in-vivo-car-t-biotechs-to-follow-closely-dc0f4ffe6d379abbPharma Surgeen2026-06-17T13:00:00.000ZEight in vivo CAR T biotechs to follow closelyhttps://www.pharmaradar360.com/article/checking-out-a-book-at-libraries-across-the-greater-sacramento-region-check-your-67abab5850c572d8Pharma Surgeen2026-06-17T13:00:00.000ZChecking out a book at libraries across the Greater Sacramento region? Check your blood pressure too.https://www.pharmaradar360.com/article/beyond-administration-time-to-overhaul-nsfas-as-we-know-it-fa2e9154cbe4f749Pharma Surgeen2026-06-17T12:54:46.000ZBeyond administration: time to overhaul NSFAS as we know ithttps://www.pharmaradar360.com/article/college-schedule-remains-hot-and-cool-during-summer-months-74c28116185a9c24Pharma Surgeen2026-06-17T12:52:52.000ZCollege schedule remains hot, and cool, during summer monthshttps://www.pharmaradar360.com/article/alumni-gathering-in-wyoming-draws-enthusiasm-9e781101f8df2053Pharma Surgeen2026-06-17T12:51:34.000ZAlumni gathering in Wyoming draws enthusiasmhttps://www.pharmaradar360.com/article/new-faculty-spotlight-logan-kludt-lawrence-dds-d9e71e5b2642574cPharma Surgeen2026-06-17T12:50:13.000ZNew faculty spotlight: Logan Kludt Lawrence, DDShttps://www.pharmaradar360.com/article/h0444c-nilotinib-teva-caps-200mg-cap-bt-x-112-27857c566fc103e2Pharma Surgeen2026-06-17T12:46:23.000ZΑνάκληση της παρτίδας H0444C του φαρμακευτικού προϊόντος NILOTINIB/TEVA caps 200mg/cap BT x 112https://www.pharmaradar360.com/article/ozempic-and-wegovy-linked-to-surprising-drop-in-violent-behavior-555d17f8adcbeae9Pharma Surgeen2026-06-17T12:38:50.000ZOzempic and Wegovy linked to surprising drop in violent behaviorhttps://www.pharmaradar360.com/article/erasmus-magazine-wins-two-national-journalism-awards-b75b2557e2bdbccdPharma Surgeen2026-06-17T12:34:00.000ZErasmus Magazine wins two national journalism awardshttps://www.pharmaradar360.com/article/hse-and-system-c-roll-out-careflow-pharmacy-across-ireland-fc7e81287b7dba60Pharma Surgeen2026-06-17T12:30:20.000ZHSE and System C roll out CareFlow Pharmacy across Irelandhttps://www.pharmaradar360.com/article/la-milanesiana-al-via-la-collaborazione-tra-humanitas-e-la-rassegna-culturale-di-c122109ed1bbe2a0Pharma Surgeen2026-06-17T12:27:44.000ZLa Milanesiana: al via la collaborazione tra Humanitas e la rassegna culturale di Elisabetta Sgarbihttps://www.pharmaradar360.com/article/guidance-covid-19-test-validation-approved-products-b6e59e8cc7937e4bPharma Surgeen2026-06-17T12:25:05.000ZGuidance: COVID-19 test validation approved productshttps://www.pharmaradar360.com/article/hospitals-warn-of-increase-in-domestic-abuse-during-the-football-world-cup-0f29c37a2af2a46cPharma Surgeen2026-06-17T12:07:20.000ZHospitals warn of increase in domestic abuse during the Football World Cuphttps://www.pharmaradar360.com/article/kff-polling-on-health-information-and-trust-335a5fc9b13fbfd7Pharma Surgeen2026-06-17T12:00:25.000ZKFF Polling on Health Information and Trusthttps://www.pharmaradar360.com/article/eucope-welcomes-diego-ardigo-as-new-chair-of-the-board-344ce753b23dd076Pharma Surgeen2026-06-17T12:00:04.000ZEUCOPE welcomes Diego Ardigò as new Chair of the Boardhttps://www.pharmaradar360.com/article/a-space-telescope-is-falling-to-earth-nasa-is-racing-to-rescue-it-3596f5fe3b26972bPharma Surgeen2026-06-17T12:00:00.000ZA space telescope is falling to Earth. NASA is racing to rescue ithttps://www.pharmaradar360.com/article/kff-tracking-poll-on-health-information-and-trust-use-of-social-media-and-ai-for-30650fa9552cf1acPharma Surgeen2026-06-17T12:00:00.000ZKFF Tracking Poll on Health Information and Trust: Use of Social Media and AI For Health Information and Advicehttps://www.pharmaradar360.com/article/warneford-park-mental-health-and-medical-research-campus-development-gets-green-d72b746a7491f044Pharma Surgeen2026-06-17T11:46:00.000ZWarneford Park: Mental health and medical research campus development gets green light from Oxford City Councilhttps://www.pharmaradar360.com/article/le-dr-denis-mukwege-au-chu-de-toulouse-cd7bc03713de241fPharma Surgeen2026-06-17T11:45:54.000ZLe Dr Denis Mukwege au CHU de Toulousehttps://www.pharmaradar360.com/article/common-plastic-chemical-linked-to-lifelong-anxiety-in-new-study-f70b0814e4e98c95Pharma Surgeen2026-06-17T11:35:01.000ZCommon plastic chemical linked to lifelong anxiety in new studyhttps://www.pharmaradar360.com/article/absorption-metabolism-and-excretion-of-single-dose-oral-14c-camizestrant-in-heal-829545f9b9d5d479Pharma Surgeen2026-06-17T11:18:48.000ZAbsorption, metabolism, and excretion of single-dose oral [14C]camizestrant in healthy human female participantshttps://www.pharmaradar360.com/article/sabr-radiotherapy-slashes-the-time-needed-to-treat-some-early-stage-prostate-can-0e9e7d576825619dPharma Surgeen2026-06-17T11:16:05.000ZSABR radiotherapy slashes the time needed to treat some early-stage prostate cancershttps://www.pharmaradar360.com/article/big-ebola-outbreak-puts-spotlight-on-little-known-virus-5d2399c1ed38e5ebPharma Surgeen2026-06-17T11:15:00.000ZBig Ebola outbreak puts spotlight on little-known virushttps://www.pharmaradar360.com/article/generation-of-frameshift-mutated-tgf-r2-specific-t-cells-in-healthy-subjects-fol-77f3c9ab6702dfe0Pharma Surgeen2026-06-17T11:12:53.000ZGeneration of frameshift‑mutated TGFβR2‑specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV‑1/GM‑CSF in a phase 1 studyhttps://www.pharmaradar360.com/article/randomized-phase-i-studies-to-evaluate-the-safety-tolerability-and-pharmacokinet-a339281d8587bce4Pharma Surgeen2026-06-17T11:09:27.000ZRandomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of an inhaled, TMEM16A potentiator, GDC-6988, in healthy subjectshttps://www.pharmaradar360.com/article/novo-nordisk-opens-czech-plant-and-unveils-29m-upgrade-to-china-facility-98c42227f0335d24Pharma Surgeen2026-06-17T11:08:00.000ZNovo Nordisk opens Czech plant and unveils $29M upgrade to China facilityhttps://www.pharmaradar360.com/article/whoop-healthex-partner-to-connect-members-medical-records-and-biometric-data-c649bb3984ff8d4fPharma Surgeen2026-06-17T11:03:00.000ZWhoop, HealthEx partner to connect members’ medical records and biometric datahttps://www.pharmaradar360.com/article/what-does-it-mean-to-be-diagnosed-with-li-fraumeni-syndrome-9cfc03c54ba61ea8Pharma Surgeen2026-06-17T11:01:24.000ZWhat Does It Mean to Be Diagnosed With Li-Fraumeni Syndrome?https://www.pharmaradar360.com/article/a-phase-1-multiple-ascending-dose-healthy-volunteer-study-to-evaluate-the-safety-bfd3c74fb35de3b6Pharma Surgeen2026-06-17T11:01:18.000ZA Phase-1 multiple ascending dose healthy volunteer study to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, a dry powder formulation of a selective inhaled potentiator of TMEM16Ahttps://www.pharmaradar360.com/article/the-earliest-plague-epidemics-may-have-been-caused-by-marmots-230ccd9c8576306cPharma Surgeen2026-06-17T11:00:00.000ZThe earliest plague epidemics may have been caused by marmotshttps://www.pharmaradar360.com/article/gsk-runs-first-dtc-ad-for-would-be-asthma-blockbuster-exdensur-c829844abc042e7dPharma Surgeen2026-06-17T10:56:00.000ZGSK runs first DTC ad for would-be asthma blockbuster Exdensurhttps://www.pharmaradar360.com/article/can-ai-predict-the-regulatory-future-fe8687a01e8c1a3fPharma Surgeen2026-06-17T10:55:57.000ZCan AI predict the (regulatory) future?https://www.pharmaradar360.com/article/mass-balance-recovery-absorption-metabolism-and-excretion-of-elinzanetant-in-hea-85c6fdb98d72f612Pharma Surgeen2026-06-17T10:53:55.000ZMass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro Biotransformationhttps://www.pharmaradar360.com/article/novo-security-breach-claimed-by-hacking-groups-seeking-multi-million-dollar-rans-ebfd9f453c7df2edPharma Surgeen2026-06-17T10:49:00.000ZNovo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reportshttps://www.pharmaradar360.com/article/edgewise-reports-positive-top-line-results-from-phase-ii-cirrus-hcm-trial-133b66b6aeca5031Pharma Surgeen2026-06-17T10:25:28.000ZEdgewise reports positive top-line results from Phase II CIRRUS-HCM trialhttps://www.pharmaradar360.com/article/new-oxford-centre-for-women-s-mental-health-established-8f47827d60591e33Pharma Surgeen2026-06-17T10:22:00.000ZNew Oxford Centre for Women’s Mental Health establishedhttps://www.pharmaradar360.com/article/aviadobio-broadens-vmix-gene-silencing-licence-with-king-s-college-london-9ec3973d75dab377Pharma Surgeen2026-06-17T10:17:57.000ZAviadoBio broadens vMiX gene silencing licence with King’s College Londonhttps://www.pharmaradar360.com/article/after-fda-sign-off-colorado-s-drug-import-plan-faces-tough-road-ahead-1f91a63779850ba7Pharma Surgeen2026-06-17T10:14:00.000ZAfter FDA sign-off, Colorado's drug import plan faces tough road aheadhttps://www.pharmaradar360.com/article/nortiva-purrs-into-action-with-long-acting-lynx-platform-salvaged-from-langer-st-4dbff6d9bb21d934Pharma Surgeen2026-06-17T10:04:00.000ZNortiva purrs into action with long-acting Lynx platform salvaged from Langer startuphttps://www.pharmaradar360.com/article/nortiva-purrs-into-action-with-long-acting-lynx-platform-salvaged-from-langer-st-848e1c5ce3bf79d3Pharma Surgeen2026-06-17T10:04:00.000ZNortiva purrs into action with long-acting Lynx platform salvaged from Langer startuphttps://www.pharmaradar360.com/article/solving-data-problems-with-casual-human-biology-q-a-with-dr-brent-richards-fd8ed02f0e6a8f7cPharma Surgeen2026-06-17T10:00:00.000ZSolving Data Problems with Casual Human Biology: Q&A with Dr. Brent Richardshttps://www.pharmaradar360.com/article/the-industry-s-interest-in-vaccine-platforms-3b0e3ef4c397183cPharma Surgeen2026-06-17T10:00:00.000ZThe Industry's Interest in Vaccine Platformshttps://www.pharmaradar360.com/article/where-does-boehringer-ingelheim-stand-between-oral-or-injectable-glp-1-s-being-t-771486edff29567fPharma Surgeen2026-06-17T10:00:00.000ZWhere Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?https://www.pharmaradar360.com/article/how-behavioral-and-engagement-insights-improve-persistence-in-patient-support-pr-bd6fc12274fd50c7Pharma Surgeen2026-06-17T10:00:00.000ZHow Behavioral and Engagement Insights Improve Persistence in Patient Support Programshttps://www.pharmaradar360.com/article/how-to-get-men-to-the-doctor-fe7117a88384757ePharma Surgeen2026-06-17T10:00:00.000ZHow to get men to the doctorhttps://www.pharmaradar360.com/article/why-one-life-insurer-is-going-big-on-health-incentives-91c15215e7ad9b78Pharma Surgeen2026-06-17T09:52:00.000ZWhy one life insurer is going big on health incentiveshttps://www.pharmaradar360.com/article/gustave-roussy-et-le-congres-des-ifods-s-associent-pour-une-session-presidentiel-a353c0be59767807Pharma Surgeen2026-06-17T09:36:23.000ZGustave Roussy et le congrès des IFODS s’associent pour une session présidentielle conjointehttps://www.pharmaradar360.com/article/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates-1fc8418a2364101ePharma Surgeen2026-06-17T09:32:42.000ZEHA26: BMS touts positive multiple myeloma data for two pipeline candidateshttps://www.pharmaradar360.com/article/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates-59e32322024ba7c6Pharma Surgeen2026-06-17T09:32:42.000ZEHA26: BMS touts positive multiple myeloma data for two pipeline candidates